{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:59:07Z","timestamp":1792857547181,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021JJ30040"],"award-info":[{"award-number":["2021JJ30040"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020771","name":"Natural Science Foundation for Young Scientists of Shanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["2021KFJJ06"],"award-info":[{"award-number":["2021KFJJ06"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672225"],"award-info":[{"award-number":["81672225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.clnu.2026.106692","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:01:36Z","timestamp":1779807696000},"page":"106692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Vitamin D for multiple sclerosis as an adjuvant therapy: A network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"62","author":[{"given":"Yuheng","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingui","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1135-7876","authenticated-orcid":false,"given":"Shuguang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2_SUPPL","key":"10.1016\/j.clnu.2026.106692_bib1","first-page":"756","article-title":"The genetic basis of multiple sclerosis severity suggests central nervous system involvement","volume":"27","author":"Harroud","year":"2021","journal-title":"Multiple Sclerosis Journal"},{"issue":"10130","key":"10.1016\/j.clnu.2026.106692_bib2","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clnu.2026.106692_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nic.2016.12.001","article-title":"Multiple sclerosis: Epidemiologic, clinical, and therapeutic aspects","volume":"27","author":"Vidal-Jordana","year":"2017","journal-title":"Neuroimaging Clin"},{"issue":"2","key":"10.1016\/j.clnu.2026.106692_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nic.2016.12.001","article-title":"Multiple sclerosis","volume":"27","author":"Vidal-Jordana","year":"2017","journal-title":"Neuroimaging Clin"},{"issue":"10","key":"10.1016\/j.clnu.2026.106692_bib5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol"},{"issue":"17","key":"10.1016\/j.clnu.2026.106692_bib6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1212\/WNL.0000000000005347","article-title":"Practice guideline recommendations summary: disease-Modifying therapies for adults with multiple sclerosis: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology","volume":"90","author":"Rae-Grant","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clnu.2026.106692_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN Guideline on the pharmacological treatment of people with multiple sclerosis","volume":"24","author":"Montalban","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.clnu.2026.106692_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211039648","article-title":"Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)","volume":"14","author":"Wiendl","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"issue":"1\u20132","key":"10.1016\/j.clnu.2026.106692_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jneuroim.2008.09.004","article-title":"Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: relationships to 5-year clinical outcomes in multiple sclerosis patients","volume":"205","author":"Weinstock-Guttman","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"11","key":"10.1016\/j.clnu.2026.106692_bib10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032003","article-title":"Interferon \u03b2 for multiple sclerosis","volume":"8","author":"Jakimovski","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7900","key":"10.1016\/j.clnu.2026.106692_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"issue":"6578","key":"10.1016\/j.clnu.2026.106692_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.clnu.2026.106692_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.beem.2011.04.009","article-title":"Vitamin D in autoimmune, infectious and allergic diseases: a vital player?","volume":"25","author":"Van Belle","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.clnu.2026.106692_bib14","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000097","article-title":"Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk","volume":"2","author":"Rhead","year":"2016","journal-title":"Neurol Genet"},{"issue":"17","key":"10.1016\/j.clnu.2026.106692_bib15","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1212\/WNL.0000000000003849","article-title":"Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS","volume":"88","author":"Gianfrancesco","year":"2017","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.clnu.2026.106692_bib16","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.2025.1604","article-title":"High-Dose vitamin D in clinically isolated syndrome typical of multiple sclerosis: the D-Lay MS randomized clinical trial","volume":"333","author":"Thouvenot","year":"2025","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clnu.2026.106692_bib17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1186\/s40001-025-02981-x","article-title":"Role of vitamin D as adjuvant therapy on multiple sclerosis: an updated systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Serag","year":"2025","journal-title":"Eur J Med Res"},{"issue":"2","key":"10.1016\/j.clnu.2026.106692_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.27270","article-title":"New Horizons for multiple sclerosis therapy: 2025 and beyond","volume":"98","author":"Sabatino","year":"2025","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.clnu.2026.106692_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.clnu.2026.106692_bib20","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"16","key":"10.1016\/j.clnu.2026.106692_bib21","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.2025.1604","article-title":"High-Dose vitamin D in clinically isolated syndrome typical of multiple sclerosis the D-Lay MS randomized clinical trial","volume":"333","author":"Thouvenot","year":"2025","journal-title":"JAMA, J Am Med Assoc"},{"issue":"20","key":"10.1016\/j.clnu.2026.106692_bib22","doi-asserted-by":"crossref","first-page":"E1906","DOI":"10.1212\/WNL.0000000000008445","article-title":"Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon \u03b2-1a","volume":"93","author":"Hupperts","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.clnu.2026.106692_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106567","article-title":"Neuroprotective role of high dose vitamin D supplementation in multiple sclerosis: sub-analysis of the EVIDIMS trial","volume":"101","author":"Gomez-Figueroa","year":"2025","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.clnu.2026.106692_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102512","article-title":"Clinical outcome measures in multiple sclerosis: a review","volume":"19","author":"Inojosa","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.clnu.2026.106692_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/1352458514554053","article-title":"Effect of Alfacalcidol on multiple sclerosis-related fatigue: a randomized, double-blind placebo-controlled study","volume":"21","author":"Achiron","year":"2015","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.clnu.2026.106692_bib26","first-page":"802796","article-title":"A randomised, double-blind, placebo-controlled trial with vitamin D3 in MS: subgroup analysis of patients with baseline disease activity despite interferon treatment","volume":"2012","author":"\u00c5ivo","year":"2012","journal-title":"Multiple Sclerosis International"},{"issue":"6","key":"10.1016\/j.clnu.2026.106692_bib27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000439278","article-title":"Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial","volume":"22","author":"Ashtari","year":"2015","journal-title":"Neuroimmunomodulation"},{"issue":"10","key":"10.1016\/j.clnu.2026.106692_bib28","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1080\/01616412.2016.1227913","article-title":"High dose Vitamin D intake and quality of life in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial","volume":"38","author":"Ashtari","year":"2016","journal-title":"Neurol Res"},{"key":"10.1016\/j.clnu.2026.106692_bib29","article-title":"Vitamin D and disease severity in multiple sclerosis-baseline data from the randomized controlled trial (EVIDIMS)","volume":"11","author":"Baecker-Koduah","year":"2020","journal-title":"Front Neurol"},{"issue":"9","key":"10.1016\/j.clnu.2026.106692_bib30","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/acn3.51148","article-title":"Effect of vitamin D supplementation on N-glycan branching and cellular immunophenotypes in MS","volume":"7","author":"Baecker-Koduah","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"8","key":"10.1016\/j.clnu.2026.106692_bib31","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.scispo.2021.12.014","article-title":"The effect of home-based aerobic training and vitamin D supplementation on fatigue and quality of life in patients with multiple sclerosis during COVID-19 outbreak","volume":"37","author":"Bahmani","year":"2022","journal-title":"Sci Sports"},{"key":"10.1016\/j.clnu.2026.106692_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103693","article-title":"Home-based aerobic training and vitamin D improve neurotrophins and inflammatory biomarkers in MS patients","volume":"60","author":"Bahmani","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"10.1016\/j.clnu.2026.106692_bib33","first-page":"180","article-title":"Impact of supplementation with \"multivitamin-mineral\" specially formulated to improve fatigue and inflammatory state in patients with multiple sclerosis: a triple-blind, randomized, placebo-controlled trial","volume":"19","author":"Bitarafan","year":"2020","journal-title":"Iranian Journal of Neurology"},{"issue":"23","key":"10.1016\/j.clnu.2026.106692_bib34","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","article-title":"A phase I\/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis","volume":"74","author":"Burton","year":"2010","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.clnu.2026.106692_bib35","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000597","article-title":"Cholecalciferol in relapsing-remitting MS: a randomized clinical trial (CHOLINE)","volume":"6","author":"Camu","year":"2019","journal-title":"Neurology-Neuroimmunology & Neuroinflammation"},{"key":"10.1016\/j.clnu.2026.106692_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101957","article-title":"High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial","volume":"59","author":"Cassard","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.clnu.2026.106692_bib37","article-title":"High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial","volume":"6","author":"Doerr","year":"2020","journal-title":"Multiple Sclerosis Journal-Experimental Translational and Clinical"},{"key":"10.1016\/j.clnu.2026.106692_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jbmt.2023.04.069","article-title":"Efficacy of ultraviolet B radiation versus vitamin D3 on postural control and cognitive functions in relapsing-remitting multiple sclerosis: a randomized controlled study","volume":"35","author":"Essa","year":"2023","journal-title":"J Bodyw Mov Ther"},{"issue":"2","key":"10.1016\/j.clnu.2026.106692_bib39","first-page":"67","article-title":"Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: preliminary findings of a randomized-controlled trial","volume":"14","author":"Etemadifar","year":"2015","journal-title":"Iranian Journal of Neurology"},{"issue":"3","key":"10.1016\/j.clnu.2026.106692_bib40","first-page":"423","article-title":"High dose vitamin D on Interleukin-10 in multiple sclerosis: a randomised, Double-Blind, placebo-controlled clinical trial","volume":"22","author":"FereshtehAshtari","year":"2016","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.clnu.2026.106692_bib41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2377-13-60","article-title":"Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties","volume":"13","author":"Golan","year":"2013","journal-title":"BMC Neurol"},{"issue":"9","key":"10.1016\/j.clnu.2026.106692_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1772","article-title":"Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients","volume":"10","author":"Hanninen","year":"2020","journal-title":"Brain and Behavior"},{"issue":"1","key":"10.1016\/j.clnu.2026.106692_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12883-017-0851-0","article-title":"High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial","volume":"17","author":"Holm\u00f8y","year":"2017","journal-title":"BMC Neurol"},{"issue":"8","key":"10.1016\/j.clnu.2026.106692_bib44","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/1352458511434607","article-title":"Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial","volume":"18","author":"Kampman","year":"2012","journal-title":"Multiple Sclerosis Journal"},{"issue":"14","key":"10.1016\/j.clnu.2026.106692_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147592","article-title":"Can vitamin D reduce inflammation? The influence of supplementation on selected immunological markers","volume":"25","author":"Lis","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1-2","key":"10.1016\/j.clnu.2026.106692_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0165-5728(02)00396-X","article-title":"Cytokine profile in patients with multiple sclerosis following vitamin D supplementation","volume":"134","author":"Mahon","year":"2003","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.clnu.2026.106692_bib47","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/08820139.2011.573041","article-title":"Therapeutic effect of vitamin D3 in multiple sclerosis patients","volume":"40","author":"Mosayebi","year":"2011","journal-title":"Immunol Investig"},{"key":"10.1016\/j.clnu.2026.106692_bib48","series-title":"Regulation of the stress-axis by vitamin D3 in subjects with multiple sclerosis; a double-blinded, randomized, placebo-controlled Study","author":"Rolf","year":"2014"},{"issue":"10","key":"10.1016\/j.clnu.2026.106692_bib49","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1177\/1352458517722646","article-title":"Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis","volume":"24","author":"Rolf","year":"2018","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.clnu.2026.106692_bib50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.molimm.2018.12.001","article-title":"Correlation of different cellular assays to analyze T cell-related cytokine profiles in vitamin D3-supplemented patients with multiple sclerosis","volume":"105","author":"Rolf","year":"2019","journal-title":"Mol Immunol"},{"issue":"3","key":"10.1016\/j.clnu.2026.106692_bib51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/1352458516654310","article-title":"Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis","volume":"23","author":"Rosjo","year":"2017","journal-title":"Multiple Sclerosis Journal"},{"issue":"1","key":"10.1016\/j.clnu.2026.106692_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/ane.13185","article-title":"Vitamin D3 supplementation and neurofilament light chain in multiple sclerosis","volume":"141","author":"Smolders","year":"2020","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.clnu.2026.106692_bib53","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2011-301876","article-title":"A randomised, double blind, placebo controlled trial with vitamin D 3 as an add on treatment to interferon \u03b2-1b in patients with multiple sclerosis","volume":"83","author":"Soilu-H\u00e4nninen","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clnu.2026.106692_bib54","volume":"vol. 80","author":"Sotirchos","year":"2013"},{"issue":"9","key":"10.1016\/j.clnu.2026.106692_bib55","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00415-011-5980-6","article-title":"Can vitamin D3 supplementation prevent bone loss in persons with MS? A placebo-controlled trial","volume":"258","author":"Steffensen","year":"2011","journal-title":"J Neurol"},{"issue":"17","key":"10.1016\/j.clnu.2026.106692_bib56","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182343274","article-title":"A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis","volume":"77","author":"Stein","year":"2011","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.clnu.2026.106692_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/nu17142271","article-title":"Does vitamin D supplementation slow brain volume loss in multiple sclerosis? A 4-Year observational Study","volume":"17","author":"Galus","year":"2025","journal-title":"Nutrients"},{"issue":"13","key":"10.1016\/j.clnu.2026.106692_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/nu15132978","article-title":"The role of vitamin D in neuroprotection in multiple sclerosis: an update","volume":"15","author":"Sangha","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.clnu.2026.106692_bib59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11011-025-01678-8","article-title":"Epstein-Barr virus infection and vitamin D deficiency are both \"causal\" for multiple sclerosis (MS) - could the common denominator be their effects on hepcidin levels?","volume":"40","author":"van Rensburg","year":"2025","journal-title":"Metab Brain Dis"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426001196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426001196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:40:24Z","timestamp":1790869224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561426001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":59,"alternative-id":["S0261561426001196"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106692","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D for multiple sclerosis as an adjuvant therapy: A network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106692"}}